Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
Healthcare & PharmaceuticalCompany Update

Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit

January 23, 2026 9:00 AM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing nucleic acid delivery technology for targets beyond the liver, announced today that it will be presenting at the 5th mRNA-Based Therapeutics Summit Europe, being held January 28-29, 2026, in Berlin. Covadonga Pañeda, Ph.D., Altamira Therapeutics' Chief Operating Officer, will give a presentation entitled "CycloPhore &...

Read more
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
Healthcare & PharmaceuticalCompany Update

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony

January 23, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Steve Darling from Proactive https://youtu.be/8EErx6aQEXs to announce that the company was honored with the opportunity to ring the Nasdaq Opening Bell at the Nasdaq MarketSite in New York's Times...

Read more
Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study
Healthcare & PharmaceuticalCompany Update

Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study

January 23, 2026 1:50 AM

Cantargia AB (Publ) (STO:CANTA) today reported that the first patient has been dosed in a Phase 1b/2 clinical trial investigating nadunolimab in combination with checkpoint inhibitor therapy in up to 24 patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC). The study is an investigator-led initiative in collaboration with Dr. Dan Fang at Tisch Cancer Institute, Icahn School of Medicine at Mount...

Read more
Monthly New Moon Circle Invites Community to Reset, Release, and Reimagine
Healthcare & PharmaceuticalAdvertorial

Monthly New Moon Circle Invites Community to Reset, Release, and Reimagine

January 22, 2026 5:20 PM

The Neurodivergent Empowerment Institute (NEI) will host its upcoming New Moon Circle Monthly, on the Sunday closest to the New Moon, offering a guided, trauma-informed community experience centered on the theme "Reset, Release, Reimagine." Rooted in NEI's mission to support emotional regulation, self-understanding, and inclusive community spaces, the New Moon Circle provides a structured pause point within the lunar cycle; an intentional moment...

Read more
BioResearch Partner(TM) Expands Into Georgia
Healthcare & PharmaceuticalPartnerships

BioResearch Partner(TM) Expands Into Georgia

January 22, 2026 5:10 PM

One of South Florida's most luminary clinical research site management organizations has expanded its clinical research footprint into the City of Atlanta, GA, strategically positioning BioResearch Partner™ across north, south, and east Atlanta, and extends access to diverse, high-growth communities and reinforcing BRP's role as a vanguard in national clinical site development. Building on its proven success in South Florida, BioResearch...

Read more
trusti and The PrEP Clinic Launch Ontario Pilot to Expand Free Rapid HIV Screening and Access to PrEP and HIV Care
Healthcare & PharmaceuticalCompany Update

trusti and The PrEP Clinic Launch Ontario Pilot to Expand Free Rapid HIV Screening and Access to PrEP and HIV Care

January 22, 2026 10:35 AM

trusti, Canada's latest at-home rapid STI testing platform, has announced a new pilot partnership with The PrEP Clinic, Ontario's full-service HIV prevention and treatment provider. The collaboration makes trusti's rapid HIV test kits available at no cost through The PrEP Clinic as a preliminary screening tool, while establishing The PrEP Clinic as a referral partner for any trusti client across Ontario who requires confirmatory testing, HIV...

Read more
Diversatek Healthcare Announces the Launch of the EZ-Ject Injection Needle
Healthcare & PharmaceuticalProduct Announcements

Diversatek Healthcare Announces the Launch of the EZ-Ject Injection Needle

January 22, 2026 10:00 AM

Diversatek Healthcare, a provider of gastrointestinal devices and diagnostic testing systems, has launched its EZ-Ject™ Injection Needle, expanding its proven line of high-performance therapeutic endoscopy devices. The EZ-Ject Injection Needle features a one-step locking mechanism that secures the needle in place with no twisting required. A Diversatek Healthcare customer described the locking mechanism as "simple and secure," highlighting...

Read more
Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
Healthcare & PharmaceuticalCompany Update

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

January 22, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today provided updates regarding the company's strategic focus on its rare disease development program for crofelemer, which is focused on near-term milestones for the treatment of intestinal failure in patients with short bowel syndrome (SBS-IF) and microvillus inclusion disease (MVID). The company has received Orphan Drug Designation for both diseases for crofelemer in the US and EU. This development effort is...

Read more
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity
Healthcare & PharmaceuticalProduct Announcements

Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

January 22, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a leader in innovative patent-pending sublingual delivery technologies, today announced it has taken delivery of two million units of its flagship caffeine supplement, BUZZ BOMB™. This delivery marks a critical milestone in Aspire's commercialization strategy, introducing a comprehensive brand relaunch and redesigned packaging. The new aesthetic is engineered for high-impact shelf presence and...

Read more
vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO's Forward-Looking Vision for Environmentally Friendly Oral Health
Healthcare & PharmaceuticalCompany Update

vVARDIS Advances Sustainable, Drill-Free Caries Management Consistent With WHO's Forward-Looking Vision for Environmentally Friendly Oral Health

January 22, 2026 7:25 AM

vVARDIS, a Swiss high-growth healthcare company welcomes the release of the World Health Organisation's (WHO) Guideline on Environmentally Friendly and Less Invasive Oral Health Care for Preventing and Managing Dental Caries, a global crisis affecting an estimated 2.5 billion people worldwide, according to the WHO. This guideline supports the Bangkok Declaration and the transition to preventive, less invasive, climate resilient, environmentally...

Read more
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

January 22, 2026 7:00 AM

Bristol Myers Squibb (NYSE:BMY, "BMS"), a global leader in oncology, announced an agreement with Microsoft, a market leader in AI-powered radiology and clinical workflow technologies, aiming to accelerate early detection of lung cancer. Through this digital health collaboration, U.S. FDA-cleared radiology AI algorithms will be deployed via Microsoft's Precision Imaging Network, part of Microsoft for Healthcare radiology solutions. Today, more...

Read more
Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health
Healthcare & PharmaceuticalCompany Update

Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health

January 22, 2026 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced that it has entered into a contract manufacturing and service agreement with Rahm Sensor Development, a technology company advancing contact-free, multi-sensor monitoring solutions for high-risk environments. Under the agreement, Zomedica will manufacture...

Read more
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target
Healthcare & PharmaceuticalCompany Update

Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target

January 22, 2026 6:00 AM

Emerging Growth Research today released a Flash Research Update on Immuron Limited (Nasdaq:IMRN), maintaining its Buy-Extended rating and 12-month price target of $3.50 following the Company's release of first-half fiscal year 2026 operating results. The Flash Report notes that Immuron reported global revenue of AUD$4.2 million for the six months ended December 31, 2025, representing a 5% increase compared to the prior-year period. Sales growth...

Read more
Preventative Oral Healthcare Tips for 2026 Shared by Dentist Dr. Andrea Joy Smith, DICOI
Healthcare & PharmaceuticalCompany Update

Preventative Oral Healthcare Tips for 2026 Shared by Dentist Dr. Andrea Joy Smith, DICOI

January 22, 2026 12:40 AM

Dr. Andrea Joy Smith has shared updated guidance on preventative dental care to help patients reduce the risk of common oral health problems in 2026 in a new blog post. Nearly half of adults over the age of 30 experience some form of gum disease, and many also develop other preventable oral health issues such as tooth decay, enamel wear, or jaw-related symptoms over time. Preventative dental care focuses on identifying and addressing concerns...

Read more
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services

January 21, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces that it has engaged i2i Marketing Group, LLC (1107 Key Plaza, Suite 222, Key West, FL 33040, USA; email: [email protected]; telephone: (240) 315-4665; Contact: Joe Grubb) to provide market awareness and corporate communications services, including through content creation, project management, third-party media distribution, and...

Read more
Neuro Serge Reviews (2026 URGENT REPORT) Cognitive Support Benefits, Risks & Who Should Avoid It
Healthcare & PharmaceuticalAdvertorial

Neuro Serge Reviews (2026 URGENT REPORT) Cognitive Support Benefits, Risks & Who Should Avoid It

January 21, 2026 5:45 PM

Cognitive decline, brain fog, and focus loss are no longer slow-burning problems, they're immediate performance blockers, and millions are feeling them daily. That urgency is exactly why Neuro Serge Reviews exploded going into 2026. Unlike outdated nootropics that require weeks of buildup, Neuro Serge is widely reported to deliver noticeable cognitive clarity, sharper focus, and mental energy within days, without stimulants, crashes, or side...

Read more
From Policy to Practice: Wendy Gregg's Impact on Assisted Living and Medicaid Integration
Healthcare & PharmaceuticalCompany Update

From Policy to Practice: Wendy Gregg's Impact on Assisted Living and Medicaid Integration

January 21, 2026 2:59 PM

Healthcare executive and consultant Wendy Gregg, MSW, MBA, continues to translate healthcare policy into practical solutions that expand access to assisted living through effective Medicaid integration. With more than 25 years of experience across healthcare administration, senior living operations, and social services, Gregg has built a career focused on aligning regulation, funding, and care delivery to better serve underserved populations....

Read more
Electiva Announces Flagship London Hospital
Healthcare & PharmaceuticalCompany Update

Electiva Announces Flagship London Hospital

January 21, 2026 1:55 PM

Electiva Healthcare is proud to announce that it will open a new hospital in London in Summer 2026. The Electiva London Hospital will set a new standard in luxury and exclusivity in a new purpose-built development in South-West London on the banks of the River Thames. The elite hospital will become Electiva's flagship site combining patient first healthcare with a luxurious experience. It will house two fully equipped state of the art surgical...

Read more
MemoryFuel Reviews (2026 URGENT REPORT) Does This Non-Stimulant Brain Supplement Actually Improve Memory & Focus?
Healthcare & PharmaceuticalAdvertorial

MemoryFuel Reviews (2026 URGENT REPORT) Does This Non-Stimulant Brain Supplement Actually Improve Memory & Focus?

January 21, 2026 1:15 PM

In 2026, cognitive performance has quietly become one of the most valuable personal assets. Professionals, students, and aging adults alike are no longer just looking for "energy", they are searching for clarity, recall, and mental endurance without stimulation, crashes, or dependency. This shift has sparked renewed interest in non-stimulant brain support supplements that work with the brain's biology rather than forcing short-term performance...

Read more
Black Book Research Publishes 2026-2027 Update:
Healthcare & PharmaceuticalProduct Announcements

Black Book Research Publishes 2026-2027 Update: "Global Growth Opportunities for openEHR Adoption"

January 21, 2026 11:45 AM

Black Book Research today announced the availability of its updated market intelligence report, "Global Growth Opportunities for openEHR Adoption in 2026-2027." Industry stakeholders can download a complimentary copy at https://blackbookmarketresearch.com/global-growth-opportunities-for-openehr-adoption-in-2026-2027 The 2026-2027 update refreshes Black Book's baseline readiness analysis and details why openEHR's global momentum is increasingly...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?